undecaprenyl-pyrophosphate and Staphylococcal-Infections

undecaprenyl-pyrophosphate has been researched along with Staphylococcal-Infections* in 1 studies

Other Studies

1 other study(ies) available for undecaprenyl-pyrophosphate and Staphylococcal-Infections

Article	Year
Ca Nature communications, 2020, 03-19, Volume: 11, Issue:1 The lipopeptide daptomycin is used as an antibiotic to treat severe infections with gram-positive pathogens, such as methicillin resistant Staphylococcus aureus (MRSA) and drug-resistant enterococci. Its precise mechanism of action is incompletely understood, and a specific molecular target has not been identified. Here we show that Ca Topics: Anti-Bacterial Agents; Biosynthetic Pathways; Cell Wall; Daptomycin; Humans; Membrane Lipids; Membranes, Artificial; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Phosphatidylglycerols; Polyisoprenyl Phosphates; Staphylococcal Infections	2020

Article

Year

Nature communications, 2020, 03-19, Volume: 11, Issue:1

The lipopeptide daptomycin is used as an antibiotic to treat severe infections with gram-positive pathogens, such as methicillin resistant Staphylococcus aureus (MRSA) and drug-resistant enterococci. Its precise mechanism of action is incompletely understood, and a specific molecular target has not been identified. Here we show that Ca

Topics: Anti-Bacterial Agents; Biosynthetic Pathways; Cell Wall; Daptomycin; Humans; Membrane Lipids; Membranes, Artificial; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Phosphatidylglycerols; Polyisoprenyl Phosphates; Staphylococcal Infections

2020